Collegium Pharmaceutical, Inc.
COLL
$47.85
$0.340.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 285.86M | 222.15M | 197.77M | 162.76M | 119.96M |
| Total Receivables | 233.95M | 213.02M | 228.71M | 228.54M | 228.46M |
| Inventory | 38.05M | 38.15M | 37.22M | 35.56M | 38.03M |
| Prepaid Expenses | 36.16M | 56.04M | 44.00M | 21.94M | 32.37M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 19.85M | 19.85M | 19.86M | 33.45M | 25.00M |
| Total Current Assets | 613.87M | 549.21M | 527.55M | 482.26M | 443.81M |
|
|
|||||
| Total Current Assets | 613.87M | 549.21M | 527.55M | 482.26M | 443.81M |
| Net Property, Plant & Equipment | 16.68M | 18.17M | 19.40M | 20.15M | 20.78M |
| Long-term Investments | 145.93M | 147.94M | 150.76M | 162.33M | 145.96M |
| Goodwill | 145.93M | 147.94M | 150.76M | 162.33M | 145.96M |
| Total Other Intangibles | 724.98M | 780.46M | 835.93M | 891.40M | 946.88M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 105.87M | 96.86M | 97.75M | 107.45M | 77.73M |
| Total Assets | 1.61B | 1.59B | 1.63B | 1.66B | 1.64B |
|
|
|||||
| Total Accounts Payable | 7.65M | 10.89M | 17.85M | 3.93M | 3.14M |
| Total Accrued Expenses | 217.93M | 229.08M | 230.39M | 251.55M | 239.83M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 65.96M | 65.92M | 65.89M | 65.85M | 65.85M |
| Total Finance Division Other Current Liabilities | 161.40M | 158.72M | 172.58M | 188.17M | 150.60M |
| Total Other Current Liabilities | 161.40M | 158.72M | 172.58M | 188.17M | 150.60M |
| Total Current Liabilities | 452.93M | 464.61M | 486.71M | 509.51M | 459.43M |
|
|
|||||
| Total Current Liabilities | 452.93M | 464.61M | 486.71M | 509.51M | 459.43M |
| Long-Term Debt | 865.81M | 880.96M | 894.65M | 908.52M | 921.44M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.50M | 4.85M | 5.20M | 5.54M | 5.91M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 9.28M | 10.00M | 10.40M | 11.18M | 14.10M |
| Total Liabilities | 1.33B | 1.36B | 1.40B | 1.43B | 1.40B |
|
|
|||||
| Common Stock & APIC | 615.12M | 598.98M | 593.28M | 590.29M | 582.80M |
| Retained Earnings | -118.09M | -149.60M | -161.58M | -164.00M | -176.54M |
| Treasury Stock & Other | -222.22M | -217.17M | -197.26M | -197.45M | -171.99M |
| Total Common Equity | 274.81M | 232.21M | 234.43M | 228.84M | 234.28M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 274.81M | 232.21M | 234.43M | 228.84M | 234.28M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 274.81M | 232.21M | 234.43M | 228.84M | 234.28M |
|
|
|||||